As a young, dynamic and creative molecular diagnostics company, we have specialized in simple and rapid solutions for the diagnosis of severe infectious diseases in hospitalized patients. We help to combat infections effectively and detect antibiotic resistance at an early stage.
Curetis Announces Financial Results for the First Six Months of 2017
Curetis Announces Management Board Changes
AACC Annual Meeting & Clinical Lab Expo 2017, San Diego, CA, USA - 30 July to 3 August, 2017
Gemeinsame Jahrestagung Schweizerische Gesellschaft für Infektiologie, Spitalhygiene, Mikrobiologie - Basel, Switzerland - August 30 to September 1, 2017